Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 29 12:52PM ET
120.69
Dollar change
+2.41
Percentage change
2.04
%
IndexRUT P/E- EPS (ttm)-4.04 Insider Own1.44% Shs Outstand30.95M Perf Week4.88%
Market Cap3.74B Forward P/E- EPS next Y-1.72 Insider Trans-1.59% Shs Float30.53M Perf Month2.30%
Income-123.41M PEG- EPS next Q-0.97 Inst Own107.50% Short Float4.09% Perf Quarter41.31%
Sales492.68M P/S7.59 EPS this Y29.21% Inst Trans0.45% Short Ratio3.57 Perf Half Y14.83%
Book/sh6.79 P/B17.78 EPS next Y39.73% ROA-28.00% Short Interest1.25M Perf Year2.56%
Cash/sh4.32 P/C27.95 EPS next 5Y- ROE-54.86% 52W Range70.24 - 140.23 Perf YTD12.75%
Dividend Est.- P/FCF- EPS past 5Y-13.90% ROI-38.00% 52W High-13.94% Beta1.30
Dividend TTM- Quick Ratio2.02 Sales past 5Y27.64% Gross Margin67.35% 52W Low71.83% ATR (14)5.23
Dividend Ex-Date- Current Ratio2.15 EPS Y/Y TTM-3.82% Oper. Margin-23.16% RSI (14)57.73 Volatility6.34% 3.82%
Employees2000 Debt/Eq0.62 Sales Y/Y TTM19.90% Profit Margin-25.05% Recom1.25 Target Price137.50
Option/ShortYes / Yes LT Debt/Eq0.55 EPS Q/Q-88.16% Payout- Rel Volume1.09 Prev Close118.28
Sales Surprise1.78% EPS Surprise-117.73% Sales Q/Q17.67% EarningsFeb 22 AMC Avg Volume349.03K Price120.69
SMA203.72% SMA507.49% SMA20019.38% Trades Volume205,901 Change2.04%
Date Action Analyst Rating Change Price Target Change
Dec-11-23Upgrade Citigroup Neutral → Buy $110
Jul-19-23Initiated Robert W. Baird Outperform $130
Feb-07-23Initiated Wells Fargo Overweight $150
Nov-07-22Upgrade Wolfe Research Underperform → Peer Perform
Jun-09-22Downgrade Citigroup Buy → Neutral $180 → $155
Apr-06-22Initiated Wolfe Research Underperform $105
Feb-24-22Upgrade Needham Hold → Buy $135
Feb-24-22Upgrade Needham Hold → Buy
Jan-18-22Upgrade Morgan Stanley Equal-Weight → Overweight $129 → $167
Jan-12-22Upgrade BTIG Research Neutral → Buy $170
Feb-23-24 12:30PM
11:06AM
05:45AM
Feb-22-24 05:50PM
04:36PM
04:05PM Loading…
04:05PM
Feb-20-24 01:59PM
05:45AM
Feb-08-24 04:05PM
Jan-14-24 12:54PM
Jan-08-24 08:30AM
Jan-05-24 08:05AM
Jan-04-24 07:01PM
Jan-03-24 08:00AM
Dec-26-23 04:30PM
08:05AM Loading…
Nov-13-23 08:05AM
Nov-03-23 10:41AM
09:44AM
Nov-02-23 06:22PM
04:05PM
Oct-31-23 10:01AM
Oct-27-23 09:35AM
Oct-26-23 10:02AM
Oct-19-23 04:05PM
Sep-28-23 08:23AM
Sep-27-23 07:35PM
Sep-26-23 08:05AM
Sep-22-23 11:47AM
Aug-29-23 08:30AM
Aug-23-23 06:00AM
10:45AM Loading…
Aug-04-23 10:45AM
Aug-03-23 05:55PM
04:10PM
04:05PM
Jul-26-23 04:24PM
Jul-20-23 04:05PM
Jul-18-23 08:30AM
Jun-14-23 09:23AM
Jun-06-23 09:00AM
May-27-23 08:28AM
May-24-23 04:05PM
May-22-23 08:30AM
May-11-23 06:09AM
May-04-23 06:05PM
04:05PM
Apr-20-23 04:05PM
Apr-14-23 06:51PM
Apr-13-23 12:21PM
Apr-12-23 04:30PM
Apr-02-23 02:07PM
Mar-14-23 07:42AM
Mar-06-23 08:30AM
Mar-02-23 08:30AM
Feb-25-23 08:04AM
Feb-24-23 02:44PM
Feb-23-23 04:05PM
Feb-21-23 06:57AM
Feb-09-23 04:05PM
Jan-09-23 08:30AM
Dec-27-22 04:30PM
Dec-01-22 01:54PM
Nov-14-22 10:43AM
Nov-07-22 04:05PM
Nov-06-22 12:30PM
Nov-04-22 11:47AM
Nov-02-22 05:45PM
08:30AM
06:28AM
Nov-01-22 05:45PM
04:05PM
Oct-20-22 04:05PM
Sep-21-22 08:30AM
Aug-31-22 08:30AM
Aug-06-22 05:00AM
Aug-05-22 10:27AM
Aug-04-22 07:15PM
04:05PM
Jul-28-22 04:30PM
10:02AM
Jul-25-22 04:15PM
Jul-22-22 04:52PM
08:30AM
Jul-18-22 04:10PM
Jul-08-22 08:30AM
Jun-27-22 07:38AM
Jun-19-22 09:03AM
May-25-22 04:05PM
May-06-22 04:11PM
11:00AM
May-05-22 06:35PM
04:05PM
Apr-28-22 04:05PM
03:02PM
Apr-21-22 04:05PM
Apr-12-22 11:52AM
Apr-03-22 12:35PM
Mar-29-22 04:05PM
Mar-23-22 09:28AM
Mar-14-22 08:30AM
Feb-28-22 12:59PM
iRhythm Technologies, Inc. is a digital healthcare company, which engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services. It also provides solutions that detect, predict, and prevent disease. The company was founded by Uday N. Kumar in September 2006 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wilson Daniel G.EVP, Corp Dev Inv RelJan 02Sale103.317,218745,69226,629Jan 04 11:57 AM
Bobzien BriceChief Financial OfficerAug 09Sale111.291,356150,90918,608Aug 10 04:20 PM
Day Mark J.Chief Technology OfficerAug 03Option Exercise36.2248617,60355,522Aug 04 08:48 AM
Shrishrimal SumiEVP, Chief Risk OfficerJun 02Sale111.451,109123,59818,707Jun 05 04:07 PM
Wilson Daniel G.EVP, Corp Dev Inv RelMar 29Sale125.004,000500,00035,337Mar 30 07:32 PM
Day Mark J.Chief Technology OfficerMar 03Sale117.232,116248,05954,815Mar 07 02:06 PM
Devine DouglasChief Operating OfficerMar 03Sale117.231,473172,68029,566Mar 07 02:02 PM
Wilson Daniel G.EVP, Strategy Corp Dev Inv RelMar 03Sale117.231,422166,70139,337Mar 07 02:04 PM
Murphy Patrick MichaelCLO & EVP RA/QA MrktAcs & GovMar 03Sale117.2357166,93832,437Mar 07 02:09 PM